KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to -$3.6 million.

  • Teladoc Health's Cash from Financing Activities fell 61461.32% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$550.7 million, marking a year-over-year decrease of 1239511.05%. This contributed to the annual value of $8.3 million for FY2024, which is 2341.99% down from last year.
  • Teladoc Health's Cash from Financing Activities amounted to -$3.6 million in Q3 2025, which was down 61461.32% from -$549.9 million recorded in Q2 2025.
  • Teladoc Health's 5-year Cash from Financing Activities high stood at $22.2 million for Q1 2021, and its period low was -$549.9 million during Q2 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was $2.1 million (2024), whereas its average is -$25.6 million.
  • Per our database at Business Quant, Teladoc Health's Cash from Financing Activities skyrocketed by 69936.91% in 2023 and then tumbled by 1455290.41% in 2025.
  • Quarter analysis of 5 years shows Teladoc Health's Cash from Financing Activities stood at $6.6 million in 2021, then tumbled by 33.87% to $4.4 million in 2022, then crashed by 140.52% to -$1.8 million in 2023, then skyrocketed by 215.94% to $2.1 million in 2024, then plummeted by 274.54% to -$3.6 million in 2025.
  • Its Cash from Financing Activities stands at -$3.6 million for Q3 2025, versus -$549.9 million for Q2 2025 and $769000.0 for Q1 2025.